New drug aims to unclog lungs in bronchiectasis patients
NCT ID NCT07547436
First seen May 05, 2026 · Last updated May 25, 2026 · Updated 3 times
Summary
This study tests whether a new drug, SAR445399, can reduce mucus plugs in the lungs of adults with non-cystic fibrosis bronchiectasis. About 70 participants will receive either the drug or a placebo, and researchers will measure changes in mucus plug scores using CT scans over 24 weeks. The goal is to see if the drug helps clear airways and improve breathing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Pulmonary Research Institute- Site Number : 8400001
RECRUITINGLoxahatchee Groves, Florida, 33470, United States
Conditions
Explore the condition pages connected to this study.